The use of stem cells in kidney disease

Current Opinion in Organ Transplantation

Volumn 14, Issue 1, 2009, Pages 72-78

  Chhabra, Preeti ^a   Brayman, Kenneth L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Acute kidney injury; Bone marrow derived mesenchymal stem cells; Renal stem progenitor cells

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CELL DEDIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY TUBULE CELL; MESENCHYMAL STEM CELL; NONHUMAN; RENAL PROTECTION; REVIEW; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION; SURVIVAL; ACUTE DISEASE; ADULT; ADULT STEM CELL; ANIMAL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL MOTION; EMBRYONIC STEM CELL; KIDNEY; MESENCHYMAL STEM CELL TRANSPLANTATION; PATHOLOGY; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATION; REGENERATIVE MEDICINE; TRANSPLANTATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ADULT STEM CELLS; ANIMALS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY; KIDNEY DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; PLURIPOTENT STEM CELLS; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 67649213923     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328320d2f5     Document Type: Review

References (98)

1. Kellum JA, Hoste EA. Acute kidney injury: epidemiology and assessment. Scand J Clin Lab Invest Suppl 2008; 241:6-11. (Pubitemid 351883670)
2. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med 2008; 36 (4 Suppl):S146-S151.
3. Bussolati B, Tetta C, Camussi G. Contribution of stem cells to kidney repair. Am J Nephrol 2008; 28:813-822. This review summarizes the current literature on the physiological role of endogenous stem cell in renal regeneration and on the potential therapeutic strategies based on the administration of exogenous stem cell.
4. Perin L, Giuliani S, Sedrakyan S, et al. Stem cell and regenerative science applications in the development of bioengineering of renal tissue. Pediatr Res 2008; 63:467-471. This review discusses various approaches in the field of bioengineering of renal tissue including the role of stem cells from embryonic, bone marrow, endogenous and amniotic fluid.
5. Legrand M, Mik EG, Johannes T, et al. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 2008; 14:502-516.
6. Van Doorn KJ, Spapen H, Geers C, et al. Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment? Acta Anaesthesiol Scand 2008; 52:1259-1264.
7. Bellomo R, Wan L, Langenberg C, May C. Septic acute kidney injury: new concepts. Nephron Exp Nephrol 2008; 109:e95-e100.
8. Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med 2008; 36 (4 Suppl):S216-S223.
9. Dasta JF, Kane-Gill SL, Durtschi AJ, et al. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008; 23:1970-1974.
10. Yoshitomi Y, Kojima S, Ogi M, Kuramochi M. Acute renal failure in accidental hypothermia of cold water immersion. Am J Kidney Dis 1998; 31:856-859. (Pubitemid 28234640)
11. Bosan IB. Recommendations for early diagnosis of chronic kidney disease. Ann Afr Med 2007; 6:130-136. (Pubitemid 47629304)
12. Oldrizzi L. Collaboration between nephrologists, cardiologists and diabetologists and the importance of early diagnosis of CKD. G Ital Nefrol 2008; 25:8-13.
13. Freedman BI, Sedor JR. Hypertension-associated kidney disease: perhaps no more. J Am Soc Nephrol 2008; 19:2047-2051.
14. Hauser AB, Stinghen AE, Kato S, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int 2008; 28 (Suppl 3):S183-S187.
15. Golgert WA, Appel GB, Hariharan S. Recurrent glomerulonephritis after renal transplantation: an unsolved problem. Clin J Am Soc Nephrol 2008; 3:800-807.
16. Beck LH Jr, Salant DJ. Glomerular and tubulointerstitial diseases. Prim Care 2008; 35:265-296.
17. Závada J, Kideryová L, Pytlík R, Tesar V. Circulating endothelial cells and circulating endothelial progenitors in kidney disease: victims, witnesses, or accomplices? Folia Biol (Praha) 2008; 54:73-80. In this article, the role of circulating endothelial cells and endothelial precursor cells in the pathogenesis of endothelial dysfunction associated with chronic renal failure and the progression of chronic renal disease is discussed.
18. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney Int Suppl 2005; 94:S46-S49. (Pubitemid 40446496)
19. Gross P. Polycystic kidney disease: will it become treatable? Pol Arch Med Wewn 2008; 118:298-301.
20. Goldberg R, Dennen P. Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis 2008; 15:297-307. AKI is an underrecognized cause of CKD, and the importance of long-term follow-up in patients for new CKD or progression of underlying CKD or both is discussed.
21. Lin F. Stem cells in kidney regeneration following acute renal injury. Pediatr Res 2006; 59 (4 Pt 2):74R-78R. (Pubitemid 43740039)
22. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109:e102-e107. Recent advances that further our understanding of the complex interplay between innate and adaptive immunity in renal IRI are summarized in this review.
23. Liu KD, Brakeman PR. Renal repair and recovery. Crit Care Med 2008; 36 (4 Suppl):S187-S192. Experimental animal models of AKI demonstrate that renal recovery and repair involves proliferation of tubular epithelial cells and stem cell populations and the coordinated contribution of multiple growth factors. This review summarizes the cellular and molecular mechanisms of renal repair and recovery after AKI.
24. Wald FA, Figueroa Y, Oriolo AS, Salas PJ. Membrane repolarization is delayed in proximal tubules after ischemia-reperfusion: possible role of microtubule-organizing centers. Am J Physiol Renal Physiol 2003; 285:F230-F240. (Pubitemid 36871195)
25. Molitoris BA. Na(+)-K(+)-ATPase that redistributes to apical membrane during ATP depletion remains functional. Am J Physiol 1993; 265 (5 Pt 2):F693-F697. (Pubitemid 2015182)
26. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 2003; 14 (Suppl 1):S55-S61. (Pubitemid 36687041)
27. Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005; 115:1756-1764. (Pubitemid 40979714)
28. Duffield JS, Bonventre JV. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 2005; 68:1956-1961.
29. Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994; 93:2175-2188. (Pubitemid 24978965)
30. Vogetseder A, Palan T, Bacic D, et al. Proximal tubular epithelial cells are generated by division of differentiated cells in the healthy kidney. Am J Physiol Cell Physiol 2007; 292:C807-C813. This study demonstrates that generation of new cells in the proximal tubule relies on division of differentiated, normally slow-cycling cells that may rapidly enter the cycle under an adequate stimulus.
31. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15:1562-1574.
32. Duffield JS, Park KM, Hsiao LL, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005; 115:1743-1755.
33. Humphreys BD, Valerius MT, Kobayashi A, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2:284-291. Inducing ischemia-reperfusion injury in transgenic mice in which 95% of tubular epithelial cells are labeled with lacZ or RFP, the authors demonstrate that 50.5% of differentiated epithelial cells that survive injury undergo proliferative expansion 2 days after IRI. These results indicate that regeneration by surviving tubular epithelial cells is the predominant mechanism of repair after ischemic tubular injury in the adult mammalian kidney.
34. Maeshima A, Sakurai H, Nigam SK. Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol 2006; 17:188-198.
35. Challen GA, Bertoncello I, Deane JA, et al. Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol 2006; 17:1896-1912. (Pubitemid 44036174)
36. Bussolati B, Bruno S, Grange C, et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005; 166:545-555. (Pubitemid 40189050)
37. Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006; 17:2443-2456. (Pubitemid 44300960)
38. - multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol 2006; 17:3300-3314.
39. Kitamura S, Yamasaki Y, Kinomura M, et al. Establishment and characterization of renal progenitor-like cells from S3 segment of nephron in rat adult kidney. FASEB J 2005; 19:1789-1797. (Pubitemid 41598763)
40. Gupta S, Verfaillie C, Chmielewski D, et al. Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol 2006; 17:3028-3040. (Pubitemid 44707763)
41. Gupta S, Rosenberg ME. Do stem cells exist in the adult kidney? Am J Nephrol 2008; 28:607-613. This article reviews the current state of knowledge regarding adult kidney stem cells.
42. Oliver JA, Maarouf O, Cheema FH, et al. The renal papilla is a niche for adult kidney stem cells. J Clin Invest 2004; 114:795-804. (Pubitemid 39578738)
43. Lazzeri E, Crescioli C, Ronconi E, et al. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol 2007; 18:3128-3138. The identification and characterization of renal multipotent progenitor CD24+ CD133+ cells in human embryonic kidneys is reported. The ability of these cells to repair renal damage, together with their apparent lack of tumorigenicity, suggests their potential in the treatment of renal failure.
44. Kim K, Lee KM, Han DJ, et al. Adult stem cell-like tubular cells reside in the cortico-medullary junction of the kidney. Int J Clin Exp Pathol 2008; 1:232-241. This study demonstrates that the CMJ of the kidney contains label-retaining, renal-repairing, highly colony-forming multipotent stem cell-like tubular cells and suggests the CMJ as the niche of adult renal stem cells.
45. Singh SR, Liu W, Hou SX. The adult Drosophila malpighian tubules are maintained by multipotent stem cells. Cell Stem Cell 2007; 1:191-203. This study identifies multipotent stem cells in the region of lower tubules and ureters of the Malpighian tubules of Drosophila that give rise to several differentiated cells and regulate self-renewal by autocrine JAK-STAT signaling.
46. Krause DS, Theise ND, Collector MI, et al. Multiorgan, multilineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105:369-377. (Pubitemid 32455343)
47. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-147. (Pubitemid 29282067)
48. Roufosse C, Cook HT. Stem cells and renal regeneration. Nephron Exp Nephrol 2008; 109:e39-e45. This review covers the evidence for involvement of embryonic stem cells, native renal stem cells and bone marrow-derived stem cells in kidney regeneration.
49. Lin F. Renal repair: role of bone marrow stem cells. Pediatr Nephrol 2008; 23:851-861. A concise overview of the biology of bone marrow stem cells, including HSCs and MSCs, for clinical nephrologists and renal researchers is provided.
50. Gupta S, Verfaillie C, Chmielewski D, et al. A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 2002; 62:1285-1290.
51. Li L, Truong P, Igarashi P, Lin F. Renal and bone marrow cells fuse after renal ischemic injury. J Am Soc Nephrol 2007; 18:3067-3077. (Pubitemid 350223967)
52. Kale S, Karihaloo A, Clark PR, et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 2003; 112:42-49. (Pubitemid 38056374)
53. Lin F, Cordes K, Li L, et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003; 14:1188-1199. (Pubitemid 36514661)
54. Huls M, Russel FG, Masereeuw R. Insights into the role of bone marrow-derived stem cells in renal repair. Kidney Blood Press Res 2008; 31:104-110. The authors compile a critically discussed protocol from several published methods to study the contribution of bone marrow-derived cells to renal regeneration and demonstrate that eGFP-positive bone marrow-derived cells contribute to the regeneration of approximately 10% of proximal tubular mass.
55. Poulsom R, Forbes SJ, Hodivala-Dilke K, et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001; 195:229-235. (Pubitemid 32899033)
56. Bussolati B, Camussi G. Stem cells in acute kidney injury. Contrib Nephrol 2007; 156:250-258.
57. Ito T, Suzuki A, Imai E, et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 2001; 12:2625-2635. (Pubitemid 33115409)
58. Ratajczak MZ. Phenotypic and functional characterization of hematopoietic stem cells. Curr Opin Hematol 2008; 15:293-300. This article summarizes recent progress in understanding the developmental hierarchy of the stem cell compartment in hematopoietic organs and discusses assays and phenotypic markers that allow their identification.
59. Fang TC, Otto WR, Rao J, et al. Haematopoietic lineage-committed bone marrow cells, but not cloned cultured mesenchymal stem cells, contribute to regeneration of renal tubular epithelium after HgCl 2 -induced acute tubular injury. Cell Prolif 2008; 41:575-591. The aim of this study is to examine which fraction of BMCs, hematopoietic lineage marrow cells (HLMCs) or MSCs, is effective in renal tubular regeneration following acute tubular injury.
60. Morigi M, Introna M, Imberti B, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26:2075-2082. The authors demonstrate that human BM-MSC treatment can prevent AKI induced by cisplatin and prolong survival in an immunodeficient mouse model. They also show that BM-MSCs induce protection against AKI-related peritubular capillary changes.
61. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004; 15:1794-1804. (Pubitemid 38822058)
62. Herrera MB, Bussolati B, Bruno S, et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004; 14:1035-1041.
63. Lange C, Tögel F, Ittrich H, et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 2005; 68:1613-1617. (Pubitemid 43169906)
64. Tögel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289:F31-F42. (Pubitemid 40863570)
65. Deans RJ, Moseley AB.Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28:875-884.
66. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30:42-48. (Pubitemid 34059216)
67. Tögel F, Weiss K, Yang Y, et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007; 292:F1626-F1635. This study demonstrates that the unique vasculotropic, paracrine actions elicited by MSC play a significant renoprotective role after AKI.
68. Majumdar MK, Thiede MA, Haynesworth SE, et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000; 9:841-848.
69. Hung SC, Pochampally RR, Chen SC, et al. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007; 25:2363-2370.
70. Qian H, Yang H, Xu W, et al. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int J Mol Med 2008; 22:325-332. This article suggests injured kidney tissue induces rat and human MSCs to differentiate into renal tubular epithelial-like cells in vitro and in vivo, and exogenous human MSCs can home specifically to injured regions and efficiently cure rat ARF.
71. Choi S, Park M, Kim J, et al. The role of mesenchymal stem cells in the functional improvement of the chronic renal failure. Stem Cells Dev 2008. [Epub ahead of print]. Histologic analysis suggests that MSCs have positive effect against glomerulosclerosis, help preserve renal function and attenuate renal injury in CRF.
72. Togel F, Cohen A, Zhang P, et al. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 2008. [Epub ahead of print] This study investigates the long-term outcome and safety of treatment with autologous and allogeneic MSCs after AKI and the role of VEGF as one of the principal paracrine mediators of renoprotection of MSCs.
73. Kwon O, Hong SM, Sutton TA, Temm CJ. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am J Physiol Renal Physiol 2008; 295:F351-F359. The importance of preservation of peritubular capillary endothelial integrity and increasing pericytes in the recovery process of damaged renal vasculature subsequent to ischemia-reperfusion in human kidneys is demonstrated.
74. Brodsky SV, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282:F1140-F1149. (Pubitemid 34654480)
75. Bi B, Schmitt R, Israilova M, et al. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007; 18:2486-2496. (Pubitemid 47378865)
76. Imberti B, Morigi M, Tomasoni S, et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007; 18:2921-2928. In this article, it is shown that MSCs exert beneficial effects on tubular cell repair in AKI by producing the mitogenic and prosurvival factor IGF-1.
77. Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 2007; 28:219-226.
78. Togel F, Yang Y, Zhang P, et al. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol 2008; 295:F315-F321. This article demonstrates that bioluminescence technology provides a sensitive and safe tool for the repeated in-vivo tracking of infused luc/neo-MSCs in allmajor organs.
79. Ittrich H, Lange C, Tögel F, et al. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imaging 2007; 25:1179-1191.
80. Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007; 25:1737-1745. This articles discusses the influence of systemic and inflammatory states on the migration capacity of BM-MSCs. (Pubitemid 47121852)
81. Togel F, Isaac J, Hu Z, et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67:1772-1784. (Pubitemid 40577712)
82. Mazzinghi B, Ronconi E, Lazzeri E, et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 2008; 205:479-490. This article demonstrates that CXCR4 and CXCR7 play essential, but differential, role in the therapeutic homing of human renal progenitor cells in ARF.
83. Herrera MB, Bussolati B, Bruno S, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007; 72:430-441. The article suggests that CD44 and hyaluronic acid interactions recruit exogenous MSC to injured renal tissue and enhance renal regeneration.
84. Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007; 72:151-156. (Pubitemid 47067393)
85. Lazzeri E, Angelotti ML, Ballerini L, et al. The role of endothelial progenitor cells in renal disease. G Ital Nefrol 2008; 25:537-546. The pivotal role of angiogenesis and endothelial cell turnover in renal disease and allograft rejection with implications for the development of novel therapeutic strategies is discussed in this article.
86. Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007; 40:936-948. (Pubitemid 350139201)
87. You Q, Cai L, Zheng J, et al. Isolation of human mesenchymal stem cells from third-trimester amniotic fluid. Int J Gynaecol Obstet 2008; 103:149-152. MSCs expressing OCT4, positive for CD29, CD73, CD90, and CD105 and negative for CD31, CD45, and CD61 that are nontumorigenic were obtained from amniotic fluid in the third trimester.
88. Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol 2005; 16:3527-3534. (Pubitemid 46211273)
89. Sagrinati C, Ronconi E, Lazzeri E, et al. Stem-cell approaches for kidney repair: choosing the right cells. Trends Mol Med 2008; 14:277-285. The authors suggest that resident stem cells recently identified in the Bowman's capsule of adult human kidneys might prospectively be the ideal cell type for treatment of both acute and chronic renal injury.
90. Steenhard BM, IsomKS, Cazcarro P, et al. Integration of embryonic stem cells in metanephric kidney organ culture. J Am Soc Nephrol 2005; 16:1623-1631. (Pubitemid 41716469)
91. Yamamoto M, Cui L, Johkura K, et al. Branching ducts similar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells. Am J Physiol Renal Physiol 2006; 290:F52-F60.
92. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
93. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:1917-1920.
94. Lanza RP, Chuug HY, Yoo JJ, et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol 2002; 20:689-696. (Pubitemid 34734135)
95. Osafune K, Takasato M, Kispert A, et al. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development (Camb) 2005; 133:151-161. (Pubitemid 43169329)
96. Yokoo T, Ohashi T, Shen J-S, et al. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissue. Proc Natl Acad Sci U S A 2005; 102:3296-3300. (Pubitemid 40328039)
97. Yokoo T, Fukui A, Ohashi T, et al. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J Am Soc Nephrol 2006; 17:1026-1034.
98. Yokoo T, Kawamura T, Kobayashi E. Kidney organogenesis and regeneration: a new era in the treatment of chronic renal failure? Clin Exp Nephrol 2008; 12:326-331. The recent progress in the field of regenerative nephrology, focusing on the de-novo establishment of a whole kidney is discussed in this article.